| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pseudomonas Infections | 45 | 2014 | 621 | 4.600 |
Why?
|
| Pseudomonas aeruginosa | 54 | 2014 | 1272 | 4.040 |
Why?
|
| Anesthesiology | 12 | 2023 | 1120 | 2.810 |
Why?
|
| Pneumonia, Ventilator-Associated | 15 | 2014 | 279 | 2.310 |
Why?
|
| Pneumonia, Bacterial | 11 | 2011 | 315 | 1.710 |
Why?
|
| Bacterial Toxins | 22 | 2014 | 925 | 1.580 |
Why?
|
| Bronchoalveolar Lavage Fluid | 23 | 2011 | 755 | 1.480 |
Why?
|
| Intensive Care Units | 10 | 2022 | 3742 | 1.460 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2023 | 253 | 1.380 |
Why?
|
| Perioperative Care | 8 | 2023 | 1037 | 1.230 |
Why?
|
| Pulmonary Alveoli | 19 | 2008 | 652 | 0.930 |
Why?
|
| Anesthesia | 7 | 2023 | 1591 | 0.920 |
Why?
|
| Antigens, Bacterial | 12 | 2010 | 1141 | 0.850 |
Why?
|
| Laryngoscopes | 2 | 2017 | 146 | 0.830 |
Why?
|
| Respiration, Artificial | 12 | 2020 | 2630 | 0.800 |
Why?
|
| Acidosis | 1 | 2023 | 268 | 0.760 |
Why?
|
| Clinical Alarms | 1 | 2021 | 61 | 0.720 |
Why?
|
| Lung | 39 | 2020 | 9998 | 0.710 |
Why?
|
| Respiratory Tract Infections | 5 | 2012 | 1009 | 0.690 |
Why?
|
| Pore Forming Cytotoxic Proteins | 11 | 2010 | 131 | 0.690 |
Why?
|
| Critical Care | 6 | 2021 | 2690 | 0.670 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 2011 | 277 | 0.640 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2010 | 120 | 0.640 |
Why?
|
| Cataract Extraction | 1 | 2023 | 467 | 0.630 |
Why?
|
| Remote Sensing Technology | 1 | 2019 | 92 | 0.620 |
Why?
|
| Virulence | 13 | 2011 | 1299 | 0.610 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 324 | 0.610 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2021 | 354 | 0.610 |
Why?
|
| Intubation, Intratracheal | 8 | 2017 | 1331 | 0.600 |
Why?
|
| Anti-Bacterial Agents | 13 | 2020 | 7402 | 0.600 |
Why?
|
| Monitoring, Physiologic | 2 | 2022 | 1779 | 0.560 |
Why?
|
| Cataract | 1 | 2023 | 831 | 0.560 |
Why?
|
| Lung Diseases | 12 | 2008 | 1909 | 0.550 |
Why?
|
| Pulmonary Edema | 16 | 2008 | 407 | 0.480 |
Why?
|
| Respiratory Mucosa | 2 | 2008 | 438 | 0.480 |
Why?
|
| Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.470 |
Why?
|
| Drug Resistance, Bacterial | 6 | 2020 | 1048 | 0.420 |
Why?
|
| Bacterial Proteins | 14 | 2014 | 3842 | 0.410 |
Why?
|
| Antibodies, Bacterial | 8 | 2010 | 1463 | 0.400 |
Why?
|
| Medical Informatics | 1 | 2019 | 732 | 0.400 |
Why?
|
| Pleural Effusion | 8 | 1993 | 341 | 0.390 |
Why?
|
| Trachea | 3 | 2008 | 1089 | 0.390 |
Why?
|
| Pleura | 15 | 1994 | 244 | 0.390 |
Why?
|
| Pneumonia | 5 | 2010 | 2143 | 0.380 |
Why?
|
| Laryngoscopy | 1 | 2017 | 707 | 0.380 |
Why?
|
| Bronchi | 6 | 2010 | 846 | 0.380 |
Why?
|
| Glycolipids | 1 | 2012 | 206 | 0.380 |
Why?
|
| Cross Infection | 3 | 2011 | 1422 | 0.370 |
Why?
|
| Telemedicine | 2 | 2021 | 3050 | 0.360 |
Why?
|
| Azithromycin | 1 | 2012 | 199 | 0.360 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1182 | 0.360 |
Why?
|
| Acute Lung Injury | 1 | 2014 | 367 | 0.360 |
Why?
|
| Bacteriological Techniques | 3 | 2012 | 275 | 0.360 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2022 | 3621 | 0.350 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2011 | 697 | 0.340 |
Why?
|
| Inpatients | 1 | 2021 | 2544 | 0.340 |
Why?
|
| Career Choice | 1 | 2016 | 756 | 0.340 |
Why?
|
| Macrophages, Alveolar | 8 | 2008 | 411 | 0.330 |
Why?
|
| Francisella tularensis | 1 | 2010 | 60 | 0.330 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2008 | 53 | 0.320 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 2008 | 445 | 0.310 |
Why?
|
| Bacterial Adhesion | 3 | 2003 | 306 | 0.310 |
Why?
|
| Metagenome | 1 | 2012 | 448 | 0.310 |
Why?
|
| Humans | 116 | 2023 | 760617 | 0.310 |
Why?
|
| Bronchoscopes | 1 | 2008 | 64 | 0.300 |
Why?
|
| Schools, Medical | 1 | 2014 | 878 | 0.300 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2011 | 585 | 0.300 |
Why?
|
| ADP Ribose Transferases | 7 | 2011 | 90 | 0.290 |
Why?
|
| Software | 1 | 2021 | 4431 | 0.290 |
Why?
|
| Shock, Septic | 7 | 2002 | 769 | 0.280 |
Why?
|
| Phagocytes | 1 | 2008 | 295 | 0.280 |
Why?
|
| Colony Count, Microbial | 5 | 2008 | 328 | 0.280 |
Why?
|
| Rabbits | 13 | 2008 | 4770 | 0.270 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2008 | 130 | 0.270 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 391 | 0.270 |
Why?
|
| Ventilators, Mechanical | 1 | 2008 | 288 | 0.260 |
Why?
|
| Sheep | 18 | 2006 | 1436 | 0.260 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 940 | 0.260 |
Why?
|
| Awards and Prizes | 1 | 2010 | 360 | 0.260 |
Why?
|
| O Antigens | 2 | 2007 | 196 | 0.260 |
Why?
|
| APACHE | 2 | 2020 | 267 | 0.240 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5835 | 0.240 |
Why?
|
| Staphylococcal Infections | 2 | 2011 | 1406 | 0.240 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 343 | 0.240 |
Why?
|
| Exotoxins | 4 | 2010 | 121 | 0.240 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2006 | 346 | 0.240 |
Why?
|
| Yersinia pestis | 1 | 2004 | 32 | 0.240 |
Why?
|
| Quality of Health Care | 1 | 2019 | 4321 | 0.230 |
Why?
|
| Electronic Health Records | 1 | 2021 | 4803 | 0.230 |
Why?
|
| Endothelium | 6 | 2008 | 764 | 0.230 |
Why?
|
| Epithelium | 13 | 2006 | 1603 | 0.220 |
Why?
|
| Integrins | 1 | 2008 | 834 | 0.220 |
Why?
|
| Mortality | 1 | 2014 | 2899 | 0.210 |
Why?
|
| Specimen Handling | 1 | 2007 | 701 | 0.210 |
Why?
|
| Acid-Base Equilibrium | 1 | 2023 | 181 | 0.210 |
Why?
|
| Virulence Factors | 5 | 2010 | 513 | 0.210 |
Why?
|
| Body Fluids | 6 | 1996 | 320 | 0.200 |
Why?
|
| Bacterial Infections | 2 | 2008 | 1389 | 0.200 |
Why?
|
| Self-Help Groups | 1 | 2023 | 192 | 0.200 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 4242 | 0.200 |
Why?
|
| Length of Stay | 3 | 2014 | 6418 | 0.200 |
Why?
|
| School Admission Criteria | 2 | 2013 | 107 | 0.190 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2018 | 499 | 0.190 |
Why?
|
| Capillary Permeability | 7 | 2008 | 773 | 0.190 |
Why?
|
| Bronchoscopy | 1 | 2007 | 909 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 1457 | 0.190 |
Why?
|
| Animals | 75 | 2011 | 168201 | 0.190 |
Why?
|
| Biomedical Research | 2 | 2014 | 3426 | 0.190 |
Why?
|
| Hospital Mortality | 3 | 2018 | 5293 | 0.180 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2020 | 637 | 0.180 |
Why?
|
| Anesthesia, Local | 1 | 2023 | 277 | 0.180 |
Why?
|
| Personnel Selection | 2 | 2013 | 196 | 0.180 |
Why?
|
| Hospital Units | 1 | 2021 | 142 | 0.180 |
Why?
|
| Leukocidins | 2 | 2010 | 18 | 0.180 |
Why?
|
| Aspirin | 1 | 2012 | 3127 | 0.180 |
Why?
|
| Delirium | 2 | 2022 | 1665 | 0.180 |
Why?
|
| Positive-Pressure Respiration | 2 | 2003 | 638 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 578 | 0.170 |
Why?
|
| Vital Signs | 1 | 2021 | 144 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 2745 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2008 | 1985 | 0.170 |
Why?
|
| Hemorrhage | 1 | 2012 | 3418 | 0.170 |
Why?
|
| Liposomes | 5 | 2008 | 784 | 0.170 |
Why?
|
| Chemokines, CXC | 2 | 2003 | 416 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12142 | 0.160 |
Why?
|
| Pentoxifylline | 2 | 1999 | 53 | 0.160 |
Why?
|
| Hydrochloric Acid | 2 | 1998 | 76 | 0.160 |
Why?
|
| Bacteremia | 4 | 2008 | 977 | 0.160 |
Why?
|
| Neutrophils | 9 | 2011 | 3763 | 0.150 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2001 | 450 | 0.150 |
Why?
|
| Hemostasis, Surgical | 1 | 2018 | 126 | 0.150 |
Why?
|
| Quorum Sensing | 2 | 2010 | 137 | 0.150 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 1996 | 661 | 0.150 |
Why?
|
| Drug Therapy, Combination | 2 | 1999 | 6305 | 0.150 |
Why?
|
| Physicians | 1 | 2016 | 4583 | 0.150 |
Why?
|
| Male | 67 | 2022 | 360358 | 0.150 |
Why?
|
| Periodicals as Topic | 1 | 2008 | 1463 | 0.140 |
Why?
|
| Lipopolysaccharides | 3 | 2011 | 2202 | 0.140 |
Why?
|
| Cell Line | 14 | 2010 | 15576 | 0.140 |
Why?
|
| Endopeptidases | 2 | 1998 | 774 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 5 | 2010 | 6074 | 0.140 |
Why?
|
| Extracellular Space | 4 | 1993 | 562 | 0.140 |
Why?
|
| Wounds and Injuries | 4 | 2010 | 2491 | 0.140 |
Why?
|
| Heart Function Tests | 1 | 1998 | 318 | 0.140 |
Why?
|
| Postoperative Complications | 8 | 2022 | 15612 | 0.140 |
Why?
|
| Body Water | 2 | 1996 | 340 | 0.140 |
Why?
|
| Patients | 1 | 2023 | 906 | 0.140 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 636 | 0.140 |
Why?
|
| Interleukin-10 | 3 | 2002 | 1172 | 0.130 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 1998 | 352 | 0.130 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2010 | 1131 | 0.130 |
Why?
|
| Immunization, Passive | 4 | 2009 | 616 | 0.130 |
Why?
|
| Epithelial Cells | 5 | 2008 | 3672 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 745 | 0.130 |
Why?
|
| Platelet Count | 1 | 2018 | 780 | 0.130 |
Why?
|
| Clodronic Acid | 2 | 2008 | 59 | 0.130 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 455 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 11 | 2009 | 6188 | 0.130 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 298 | 0.130 |
Why?
|
| Feasibility Studies | 2 | 2021 | 5239 | 0.130 |
Why?
|
| Cystic Fibrosis | 5 | 2011 | 1285 | 0.120 |
Why?
|
| Plant Lectins | 1 | 1995 | 103 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2003 | 8166 | 0.120 |
Why?
|
| Proteomics | 1 | 2008 | 3836 | 0.120 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 4947 | 0.120 |
Why?
|
| History, 20th Century | 2 | 2014 | 2764 | 0.120 |
Why?
|
| Rats | 15 | 2008 | 23717 | 0.120 |
Why?
|
| Lysophospholipase | 2 | 2004 | 66 | 0.120 |
Why?
|
| Genomic Islands | 1 | 2014 | 52 | 0.110 |
Why?
|
| Female | 48 | 2023 | 392148 | 0.110 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 2 | 2011 | 20 | 0.110 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1650 | 0.110 |
Why?
|
| Endoscopy | 1 | 2023 | 1851 | 0.110 |
Why?
|
| DNA, Bacterial | 5 | 2014 | 1471 | 0.110 |
Why?
|
| Pleurisy | 1 | 1993 | 54 | 0.110 |
Why?
|
| Treatment Outcome | 9 | 2021 | 64568 | 0.110 |
Why?
|
| Empyema, Pleural | 1 | 1993 | 61 | 0.110 |
Why?
|
| Permeability | 5 | 1996 | 721 | 0.110 |
Why?
|
| Anesthetics, Inhalation | 1 | 1998 | 572 | 0.110 |
Why?
|
| Monokines | 3 | 2006 | 71 | 0.110 |
Why?
|
| Mothers | 1 | 2023 | 2194 | 0.100 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 992 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 1202 | 0.100 |
Why?
|
| Cytotoxins | 2 | 2007 | 153 | 0.100 |
Why?
|
| Phagocytosis | 3 | 2008 | 1526 | 0.100 |
Why?
|
| Anticoagulants | 1 | 2008 | 4785 | 0.100 |
Why?
|
| Pulmonary Gas Exchange | 4 | 2006 | 379 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2011 | 3800 | 0.100 |
Why?
|
| Video Recording | 1 | 2017 | 965 | 0.100 |
Why?
|
| Histamine Release | 1 | 2011 | 134 | 0.100 |
Why?
|
| Blood Coagulation | 2 | 2008 | 1154 | 0.100 |
Why?
|
| Language | 1 | 2021 | 1541 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2021 | 1790 | 0.100 |
Why?
|
| Culture Techniques | 1 | 2012 | 531 | 0.100 |
Why?
|
| Faculty | 1 | 2014 | 383 | 0.090 |
Why?
|
| Nasal Lavage Fluid | 1 | 2010 | 17 | 0.090 |
Why?
|
| Pulmonary Fibrosis | 2 | 2008 | 505 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1462 | 0.090 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3680 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 15251 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 1529 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2011 | 48 | 0.090 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 1992 | 238 | 0.090 |
Why?
|
| Cell Membrane Permeability | 4 | 1998 | 574 | 0.090 |
Why?
|
| Sepsis | 4 | 2002 | 2585 | 0.090 |
Why?
|
| Administration, Inhalation | 3 | 2006 | 1156 | 0.090 |
Why?
|
| Cohort Studies | 8 | 2020 | 41457 | 0.090 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 34 | 0.090 |
Why?
|
| Respiratory Function Tests | 1 | 2015 | 1683 | 0.090 |
Why?
|
| Mice | 24 | 2011 | 81368 | 0.090 |
Why?
|
| General Surgery | 1 | 2021 | 1692 | 0.090 |
Why?
|
| Aged | 24 | 2022 | 169042 | 0.090 |
Why?
|
| Histamine | 1 | 2011 | 499 | 0.090 |
Why?
|
| Bacteria | 3 | 2010 | 2192 | 0.080 |
Why?
|
| Pseudomonas Vaccines | 1 | 2009 | 24 | 0.080 |
Why?
|
| Lung Injury | 3 | 2008 | 422 | 0.080 |
Why?
|
| Biofilms | 2 | 2011 | 626 | 0.080 |
Why?
|
| Immunoglobulin G | 5 | 2010 | 4533 | 0.080 |
Why?
|
| Aztreonam | 2 | 1999 | 10 | 0.080 |
Why?
|
| Monobactams | 2 | 1999 | 16 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2010 | 302 | 0.080 |
Why?
|
| Protein C | 1 | 2009 | 133 | 0.080 |
Why?
|
| Surgical Procedures, Operative | 2 | 1998 | 1924 | 0.080 |
Why?
|
| Respiratory Mechanics | 2 | 1992 | 699 | 0.080 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2009 | 56 | 0.080 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2010 | 144 | 0.080 |
Why?
|
| Cytokines | 4 | 2008 | 7373 | 0.080 |
Why?
|
| Endotoxins | 1 | 1991 | 520 | 0.080 |
Why?
|
| Consumer Advocacy | 1 | 2009 | 82 | 0.080 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 1125 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2009 | 151 | 0.080 |
Why?
|
| Cilastatin | 2 | 1999 | 12 | 0.080 |
Why?
|
| Disease Models, Animal | 7 | 2008 | 18221 | 0.080 |
Why?
|
| Receptors, Vitronectin | 1 | 2008 | 46 | 0.080 |
Why?
|
| France | 1 | 2010 | 492 | 0.080 |
Why?
|
| Endothelium, Vascular | 4 | 1998 | 4433 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2004 | 4642 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2011 | 1936 | 0.080 |
Why?
|
| Imipenem | 2 | 1999 | 37 | 0.080 |
Why?
|
| Respiratory System | 1 | 2012 | 563 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2011 | 577 | 0.080 |
Why?
|
| Prospective Studies | 14 | 2018 | 54360 | 0.080 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2010 | 247 | 0.080 |
Why?
|
| Hemodynamics | 9 | 2001 | 4160 | 0.080 |
Why?
|
| Chemokine CXCL2 | 4 | 2006 | 106 | 0.080 |
Why?
|
| Group Processes | 1 | 2009 | 228 | 0.070 |
Why?
|
| Drug Resistance, Microbial | 1 | 2011 | 825 | 0.070 |
Why?
|
| Risk Factors | 12 | 2020 | 74115 | 0.070 |
Why?
|
| Survival Rate | 4 | 2008 | 12719 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2008 | 6520 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 376 | 0.070 |
Why?
|
| Antibodies, Blocking | 1 | 2008 | 243 | 0.070 |
Why?
|
| Airway Obstruction | 2 | 1994 | 661 | 0.070 |
Why?
|
| Abdomen | 2 | 1993 | 1128 | 0.070 |
Why?
|
| Coronary Artery Bypass | 3 | 1992 | 2188 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2008 | 2661 | 0.070 |
Why?
|
| Fimbriae, Bacterial | 2 | 2006 | 138 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 234 | 0.070 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2008 | 242 | 0.070 |
Why?
|
| Academies and Institutes | 1 | 2009 | 318 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2006 | 4341 | 0.070 |
Why?
|
| Quinolones | 1 | 2010 | 378 | 0.070 |
Why?
|
| DNA Transposable Elements | 2 | 2009 | 754 | 0.070 |
Why?
|
| Aerosols | 2 | 2002 | 635 | 0.070 |
Why?
|
| Proteins | 10 | 1997 | 6030 | 0.070 |
Why?
|
| Inspiratory Capacity | 1 | 2006 | 35 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2008 | 302 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2008 | 564 | 0.070 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2010 | 350 | 0.070 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2011 | 1017 | 0.070 |
Why?
|
| Middle Aged | 22 | 2020 | 220584 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 5491 | 0.070 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2006 | 31 | 0.070 |
Why?
|
| DNA Primers | 3 | 2010 | 2817 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2021 | 3797 | 0.070 |
Why?
|
| Smoke Inhalation Injury | 1 | 2006 | 47 | 0.070 |
Why?
|
| Pneumonia, Aspiration | 2 | 1997 | 145 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 4739 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 1738 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2009 | 632 | 0.060 |
Why?
|
| Fluoroquinolones | 1 | 2008 | 306 | 0.060 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 1997 | 426 | 0.060 |
Why?
|
| Genetic Variation | 2 | 2014 | 6561 | 0.060 |
Why?
|
| Japan | 1 | 2010 | 1372 | 0.060 |
Why?
|
| Acute Disease | 5 | 2004 | 7237 | 0.060 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2006 | 139 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 1998 | 4935 | 0.060 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1700 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2004 | 2495 | 0.060 |
Why?
|
| Patient Discharge | 1 | 2018 | 3442 | 0.060 |
Why?
|
| Sodium | 1 | 1990 | 1588 | 0.060 |
Why?
|
| Albuterol | 1 | 2006 | 213 | 0.060 |
Why?
|
| United States | 5 | 2022 | 72272 | 0.060 |
Why?
|
| Blood-Air Barrier | 3 | 1997 | 24 | 0.060 |
Why?
|
| Heart Failure | 5 | 2022 | 11669 | 0.060 |
Why?
|
| DNA | 2 | 2002 | 7196 | 0.060 |
Why?
|
| Time Factors | 4 | 2019 | 39913 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2004 | 1646 | 0.060 |
Why?
|
| Receptors, Immunologic | 2 | 2011 | 1409 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 11874 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 982 | 0.060 |
Why?
|
| History, 21st Century | 1 | 2010 | 1565 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 1993 | 1489 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 12966 | 0.060 |
Why?
|
| Hemostasis | 1 | 2007 | 469 | 0.060 |
Why?
|
| Protein Transport | 1 | 2010 | 1966 | 0.060 |
Why?
|
| Blood Pressure | 5 | 2008 | 8472 | 0.060 |
Why?
|
| Pandemics | 2 | 2022 | 8645 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2023 | 23972 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3113 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 2 | 1987 | 1580 | 0.060 |
Why?
|
| Lymphatic System | 4 | 1988 | 253 | 0.060 |
Why?
|
| Universities | 1 | 2009 | 992 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2003 | 15908 | 0.060 |
Why?
|
| Nasal Cavity | 1 | 2006 | 304 | 0.060 |
Why?
|
| Bioterrorism | 1 | 2004 | 144 | 0.060 |
Why?
|
| Mentors | 1 | 2009 | 661 | 0.060 |
Why?
|
| Microscopy, Electron | 5 | 1995 | 2561 | 0.060 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2003 | 58 | 0.050 |
Why?
|
| Dogs | 6 | 1997 | 3838 | 0.050 |
Why?
|
| Coronary Disease | 1 | 1998 | 5912 | 0.050 |
Why?
|
| Lymph | 5 | 1990 | 77 | 0.050 |
Why?
|
| Respiratory Tract Diseases | 1 | 1989 | 750 | 0.050 |
Why?
|
| Mouth | 1 | 2006 | 381 | 0.050 |
Why?
|
| Molecular Sequence Data | 7 | 2007 | 17629 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3088 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3209 | 0.050 |
Why?
|
| Ecosystem | 1 | 2007 | 487 | 0.050 |
Why?
|
| Bacterial Typing Techniques | 1 | 2003 | 263 | 0.050 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 913 | 0.050 |
Why?
|
| Serotyping | 1 | 2003 | 325 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 4 | 1988 | 273 | 0.050 |
Why?
|
| Spleen | 1 | 2008 | 2286 | 0.050 |
Why?
|
| Internship and Residency | 2 | 2013 | 5878 | 0.050 |
Why?
|
| Thorax | 1 | 1985 | 555 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 1186 | 0.050 |
Why?
|
| Drug Combinations | 2 | 1999 | 2048 | 0.050 |
Why?
|
| Phenotype | 7 | 2008 | 16571 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2003 | 262 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2137 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2010 | 1454 | 0.050 |
Why?
|
| Mixed Connective Tissue Disease | 1 | 1981 | 32 | 0.050 |
Why?
|
| Boston | 1 | 2014 | 9313 | 0.050 |
Why?
|
| Membrane Glycoproteins | 3 | 2011 | 3688 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 2222 | 0.050 |
Why?
|
| Publishing | 1 | 2008 | 832 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 1023 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 9172 | 0.050 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 13441 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2010 | 1033 | 0.050 |
Why?
|
| Chemokine CXCL1 | 2 | 2003 | 101 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2003 | 390 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 8601 | 0.050 |
Why?
|
| Adult | 19 | 2020 | 220969 | 0.040 |
Why?
|
| Preoperative Care | 2 | 2001 | 2241 | 0.040 |
Why?
|
| Base Sequence | 4 | 2010 | 12421 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 983 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1963 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 3769 | 0.040 |
Why?
|
| Biological Assay | 1 | 2003 | 626 | 0.040 |
Why?
|
| Emergency Treatment | 1 | 2003 | 495 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2008 | 1349 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 2849 | 0.040 |
Why?
|
| Equipment Design | 1 | 2007 | 3501 | 0.040 |
Why?
|
| Blood Proteins | 2 | 1984 | 1172 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2008 | 1375 | 0.040 |
Why?
|
| Escherichia coli | 1 | 1991 | 4209 | 0.040 |
Why?
|
| Nitric Oxide | 2 | 1998 | 2135 | 0.040 |
Why?
|
| Homoserine | 1 | 1998 | 12 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2011 | 14389 | 0.040 |
Why?
|
| Cathelicidins | 1 | 1998 | 80 | 0.040 |
Why?
|
| Nitrobenzenes | 1 | 1998 | 66 | 0.040 |
Why?
|
| 4-Butyrolactone | 1 | 1998 | 61 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2010 | 3900 | 0.040 |
Why?
|
| Morbidity | 1 | 2003 | 1750 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 80566 | 0.040 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 1997 | 26 | 0.040 |
Why?
|
| Sulfonamides | 2 | 1998 | 1977 | 0.040 |
Why?
|
| Pulmonary Circulation | 4 | 1997 | 737 | 0.040 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1241 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1997 | 221 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2011 | 221 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 12933 | 0.040 |
Why?
|
| Extravascular Lung Water | 2 | 1995 | 20 | 0.040 |
Why?
|
| Leukocyte Count | 3 | 1997 | 1597 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 2 | 1989 | 308 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 1997 | 129 | 0.040 |
Why?
|
| Macrophages | 3 | 2008 | 5758 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2003 | 4611 | 0.040 |
Why?
|
| Hydrostatic Pressure | 4 | 1996 | 98 | 0.040 |
Why?
|
| Anesthetics | 1 | 2003 | 523 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1996 | 1545 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 1998 | 318 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1437 | 0.040 |
Why?
|
| Leukocyte Elastase | 1 | 1997 | 114 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2011 | 1884 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 1996 | 135 | 0.030 |
Why?
|
| Albumins | 2 | 1991 | 575 | 0.030 |
Why?
|
| Critical Illness | 1 | 2009 | 2709 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3088 | 0.030 |
Why?
|
| Genes, Bacterial | 4 | 2005 | 1073 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1998 | 361 | 0.030 |
Why?
|
| Acids | 1 | 1996 | 125 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1997 | 175 | 0.030 |
Why?
|
| Absorption | 1 | 1996 | 242 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2001 | 905 | 0.030 |
Why?
|
| Iodine Radioisotopes | 2 | 1998 | 1031 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1998 | 1169 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1996 | 197 | 0.030 |
Why?
|
| Kidney | 3 | 2008 | 7045 | 0.030 |
Why?
|
| Concanavalin A | 1 | 1995 | 190 | 0.030 |
Why?
|
| Interleukin-8 | 2 | 1999 | 696 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1997 | 258 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3204 | 0.030 |
Why?
|
| Glycoconjugates | 1 | 1995 | 88 | 0.030 |
Why?
|
| Nitrogen Dioxide | 1 | 1997 | 522 | 0.030 |
Why?
|
| Logistic Models | 3 | 2011 | 13245 | 0.030 |
Why?
|
| Immunization | 1 | 1999 | 1217 | 0.030 |
Why?
|
| Species Specificity | 3 | 2011 | 2411 | 0.030 |
Why?
|
| Piperacillin | 1 | 2014 | 37 | 0.030 |
Why?
|
| Liver | 2 | 2008 | 7512 | 0.030 |
Why?
|
| Cells, Cultured | 6 | 2011 | 18937 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 141 | 0.030 |
Why?
|
| Penicillanic Acid | 1 | 2014 | 41 | 0.030 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1993 | 37 | 0.030 |
Why?
|
| Glycine | 1 | 1997 | 661 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1998 | 1415 | 0.030 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1996 | 274 | 0.030 |
Why?
|
| Growth Substances | 1 | 1996 | 768 | 0.030 |
Why?
|
| Thrombosis | 1 | 2008 | 2943 | 0.030 |
Why?
|
| Clindamycin | 1 | 2014 | 139 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2014 | 116 | 0.030 |
Why?
|
| Oxygen | 3 | 1999 | 4226 | 0.030 |
Why?
|
| Mutation | 5 | 2010 | 30016 | 0.030 |
Why?
|
| Catecholamines | 1 | 1994 | 387 | 0.030 |
Why?
|
| Burns | 1 | 2005 | 1875 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1687 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 7995 | 0.030 |
Why?
|
| Phospholipases A | 2 | 2004 | 204 | 0.030 |
Why?
|
| Mediastinum | 2 | 1985 | 266 | 0.030 |
Why?
|
| Lectins | 1 | 1995 | 489 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 58894 | 0.030 |
Why?
|
| Phylogeny | 2 | 2010 | 2806 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2003 | 12758 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 2674 | 0.030 |
Why?
|
| Pyocyanine | 1 | 2011 | 20 | 0.020 |
Why?
|
| Glycosylation | 1 | 1995 | 1098 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 1996 | 1146 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 1996 | 2214 | 0.020 |
Why?
|
| Asthma | 1 | 2010 | 6233 | 0.020 |
Why?
|
| Pulmonary Atelectasis | 1 | 1992 | 143 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10754 | 0.020 |
Why?
|
| tau Proteins | 1 | 2022 | 2094 | 0.020 |
Why?
|
| Bacterial Vaccines | 1 | 1993 | 399 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12043 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1997 | 2601 | 0.020 |
Why?
|
| Plasmids | 1 | 1996 | 2265 | 0.020 |
Why?
|
| Hypertension | 3 | 1987 | 8529 | 0.020 |
Why?
|
| Clarithromycin | 1 | 2010 | 86 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3777 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 1990 | 326 | 0.020 |
Why?
|
| Peroxidase | 3 | 1999 | 610 | 0.020 |
Why?
|
| Hydroxybutyrates | 1 | 2010 | 76 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2011 | 522 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2003 | 6346 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2010 | 127 | 0.020 |
Why?
|
| Hydrogen | 1 | 2010 | 172 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2004 | 2178 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1999 | 1810 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 14648 | 0.020 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2010 | 190 | 0.020 |
Why?
|
| Spirometry | 1 | 1992 | 928 | 0.020 |
Why?
|
| Thrombomodulin | 1 | 2009 | 105 | 0.020 |
Why?
|
| San Francisco | 1 | 2009 | 162 | 0.020 |
Why?
|
| Cell Survival | 2 | 1999 | 5780 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2014 | 783 | 0.020 |
Why?
|
| Respiratory Paralysis | 1 | 1989 | 32 | 0.020 |
Why?
|
| Antibody Affinity | 1 | 2009 | 246 | 0.020 |
Why?
|
| Gene Expression | 2 | 2001 | 7568 | 0.020 |
Why?
|
| SRS-A | 1 | 1988 | 132 | 0.020 |
Why?
|
| Oleic Acids | 1 | 1988 | 72 | 0.020 |
Why?
|
| Oleic Acid | 1 | 1988 | 92 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 6807 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1992 | 1148 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2756 | 0.020 |
Why?
|
| Hydrothorax | 1 | 1988 | 18 | 0.020 |
Why?
|
| Infant | 3 | 2011 | 36152 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1993 | 1814 | 0.020 |
Why?
|
| Esophagectomy | 1 | 1991 | 467 | 0.020 |
Why?
|
| Anesthesia, General | 4 | 1997 | 1173 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 2007 | 4172 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1992 | 1526 | 0.020 |
Why?
|
| Goats | 2 | 1999 | 165 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2011 | 8618 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2011 | 584 | 0.020 |
Why?
|
| Leukotriene B4 | 1 | 1988 | 280 | 0.020 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2008 | 200 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2009 | 612 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2011 | 42188 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2008 | 1058 | 0.020 |
Why?
|
| Larynx | 1 | 1991 | 492 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 1993 | 1602 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 1635 | 0.020 |
Why?
|
| Cardiac Output | 2 | 1986 | 831 | 0.020 |
Why?
|
| Phospholipids | 1 | 2010 | 786 | 0.020 |
Why?
|
| von Willebrand Factor | 1 | 1990 | 676 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1988 | 233 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2008 | 1157 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2001 | 9311 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 1992 | 1302 | 0.020 |
Why?
|
| Vascular Resistance | 2 | 1986 | 930 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10073 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 22115 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2008 | 471 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 1988 | 624 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2010 | 1139 | 0.020 |
Why?
|
| Models, Biological | 2 | 2006 | 9461 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20074 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2010 | 1185 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2010 | 1175 | 0.010 |
Why?
|
| Octoxynol | 1 | 2004 | 77 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2018 | 12334 | 0.010 |
Why?
|
| Mast Cells | 1 | 2011 | 1392 | 0.010 |
Why?
|
| Monocytes | 1 | 1994 | 2565 | 0.010 |
Why?
|
| Neutropenia | 1 | 2009 | 885 | 0.010 |
Why?
|
| Adolescent | 5 | 2011 | 88234 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1993 | 1230 | 0.010 |
Why?
|
| Embolism, Air | 1 | 1984 | 109 | 0.010 |
Why?
|
| Gene Library | 1 | 2007 | 1055 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2022 | 22148 | 0.010 |
Why?
|
| Child | 4 | 2011 | 80079 | 0.010 |
Why?
|
| Trauma Centers | 1 | 2009 | 936 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 15689 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12447 | 0.010 |
Why?
|
| Host-Parasite Interactions | 1 | 2006 | 300 | 0.010 |
Why?
|
| Sex Factors | 1 | 1998 | 10548 | 0.010 |
Why?
|
| Apoptosis | 2 | 2011 | 9476 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2009 | 2218 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11069 | 0.010 |
Why?
|
| Yersinia | 1 | 2003 | 9 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2004 | 276 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1989 | 1092 | 0.010 |
Why?
|
| Transfection | 2 | 2002 | 5766 | 0.010 |
Why?
|
| Eukaryotic Cells | 1 | 2004 | 191 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3410 | 0.010 |
Why?
|
| Prognosis | 4 | 2010 | 29600 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2006 | 390 | 0.010 |
Why?
|
| Pericardial Effusion | 1 | 1985 | 247 | 0.010 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2003 | 98 | 0.010 |
Why?
|
| Glycerol | 1 | 2004 | 274 | 0.010 |
Why?
|
| Cardiovascular Diseases | 2 | 2003 | 15498 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2009 | 947 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3575 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2006 | 23416 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3841 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2459 | 0.010 |
Why?
|
| Heart Atria | 2 | 1985 | 1333 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1759 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2001 | 26180 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2004 | 704 | 0.010 |
Why?
|
| Operon | 1 | 2003 | 372 | 0.010 |
Why?
|
| Dosage Forms | 1 | 2002 | 56 | 0.010 |
Why?
|
| Solvents | 1 | 2003 | 294 | 0.010 |
Why?
|
| Drug Storage | 1 | 2002 | 52 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12943 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2009 | 846 | 0.010 |
Why?
|
| Genetic Vectors | 2 | 2002 | 3392 | 0.010 |
Why?
|
| Virosomes | 1 | 2001 | 5 | 0.010 |
Why?
|
| Up-Regulation | 2 | 2003 | 4117 | 0.010 |
Why?
|
| DNA, Circular | 1 | 2002 | 96 | 0.010 |
Why?
|
| Cation Exchange Resins | 1 | 2001 | 19 | 0.010 |
Why?
|
| Enzyme Stability | 1 | 2002 | 219 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2002 | 222 | 0.010 |
Why?
|
| Drug Stability | 1 | 2002 | 291 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1994 | 2778 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 886 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2002 | 297 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1692 | 0.010 |
Why?
|
| Posture | 1 | 1985 | 956 | 0.010 |
Why?
|
| Peptides | 1 | 1993 | 4354 | 0.010 |
Why?
|
| Lipase | 1 | 2003 | 324 | 0.010 |
Why?
|
| Plant Proteins | 1 | 2003 | 369 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7847 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2009 | 2486 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15828 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2001 | 202 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 1998 | 7389 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 2002 | 641 | 0.010 |
Why?
|
| Complement Activation | 2 | 1996 | 445 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 2802 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1993 | 645 | 0.010 |
Why?
|
| Proxy | 1 | 2001 | 151 | 0.010 |
Why?
|
| Pulmonary Artery | 2 | 1985 | 1927 | 0.010 |
Why?
|
| Point Mutation | 1 | 2004 | 1595 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2003 | 1525 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2009 | 1935 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 3998 | 0.010 |
Why?
|
| Immune Sera | 1 | 1999 | 605 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1654 | 0.010 |
Why?
|
| Respiration | 1 | 1985 | 1656 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 860 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10704 | 0.010 |
Why?
|
| Intraoperative Complications | 2 | 1997 | 1161 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 2001 | 429 | 0.010 |
Why?
|
| Peroxidases | 1 | 1998 | 134 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14591 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 1988 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1998 | 452 | 0.010 |
Why?
|
| Chemokines | 1 | 2002 | 954 | 0.010 |
Why?
|
| Genotype | 2 | 2005 | 12978 | 0.010 |
Why?
|
| Regulon | 1 | 1997 | 71 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 777 | 0.010 |
Why?
|
| Smoking | 1 | 1993 | 9050 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 1998 | 321 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2006 | 3206 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2010 | 6390 | 0.010 |
Why?
|
| Curriculum | 1 | 2009 | 3738 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 8426 | 0.010 |
Why?
|
| Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 3548 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 1998 | 596 | 0.010 |
Why?
|
| Perfusion | 2 | 1995 | 1373 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 1996 | 269 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1998 | 597 | 0.010 |
Why?
|
| Cushing Syndrome | 1 | 1977 | 241 | 0.010 |
Why?
|
| Solubility | 1 | 1996 | 1089 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3730 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1977 | 569 | 0.010 |
Why?
|
| Amiloride | 1 | 1994 | 116 | 0.010 |
Why?
|
| Biological Transport | 1 | 1999 | 2089 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1994 | 86 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1994 | 361 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6126 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1996 | 675 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 1996 | 372 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1995 | 411 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 1901 | 0.010 |
Why?
|
| beta-Thromboglobulin | 1 | 1993 | 20 | 0.010 |
Why?
|
| Altitude Sickness | 1 | 1994 | 91 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1994 | 242 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1985 | 3461 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1996 | 629 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1997 | 635 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3705 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1994 | 325 | 0.010 |
Why?
|
| Counseling | 1 | 2001 | 1538 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1997 | 1230 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 1848 | 0.010 |
Why?
|
| Propranolol | 1 | 1994 | 490 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 861 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1994 | 866 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1985 | 5964 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1986 | 5486 | 0.010 |
Why?
|
| Culture Media | 1 | 1994 | 895 | 0.010 |
Why?
|
| Blood Vessels | 1 | 1997 | 1113 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 2315 | 0.010 |
Why?
|
| Epinephrine | 1 | 1994 | 792 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 5717 | 0.010 |
Why?
|
| Eosinophils | 1 | 1996 | 953 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 9345 | 0.010 |
Why?
|
| E-Selectin | 1 | 1993 | 577 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1996 | 2625 | 0.010 |
Why?
|
| Histological Techniques | 1 | 1991 | 194 | 0.010 |
Why?
|
| Microvilli | 1 | 1991 | 234 | 0.010 |
Why?
|
| Lipids | 1 | 2001 | 3332 | 0.010 |
Why?
|
| Biopsy | 1 | 1981 | 6762 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1540 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1990 | 375 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1993 | 1248 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1993 | 1131 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 2001 | 9529 | 0.000 |
Why?
|
| Central Venous Pressure | 1 | 1988 | 79 | 0.000 |
Why?
|
| Exudates and Transudates | 1 | 1988 | 174 | 0.000 |
Why?
|
| Trans-Activators | 1 | 1997 | 2852 | 0.000 |
Why?
|
| Intestines | 1 | 1996 | 1909 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1996 | 3145 | 0.000 |
Why?
|
| Hydrolysis | 1 | 1988 | 661 | 0.000 |
Why?
|
| Heart Valve Diseases | 1 | 1994 | 1028 | 0.000 |
Why?
|
| Vaccination | 1 | 1999 | 3370 | 0.000 |
Why?
|
| Plasmapheresis | 1 | 1987 | 206 | 0.000 |
Why?
|
| Autoradiography | 1 | 1987 | 728 | 0.000 |
Why?
|
| Brain Diseases | 1 | 1994 | 1545 | 0.000 |
Why?
|
| Inflammation | 1 | 2004 | 10760 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 59179 | 0.000 |
Why?
|
| Syndrome | 1 | 1990 | 3268 | 0.000 |
Why?
|
| Venous Pressure | 1 | 1983 | 56 | 0.000 |
Why?
|
| Myocardium | 1 | 1996 | 4724 | 0.000 |
Why?
|
| Cell Movement | 1 | 1996 | 5200 | 0.000 |
Why?
|
| Phrenic Nerve | 1 | 1983 | 78 | 0.000 |
Why?
|
| Hepatic Veins | 1 | 1983 | 112 | 0.000 |
Why?
|
| Cautery | 1 | 1983 | 71 | 0.000 |
Why?
|
| Insulin | 1 | 1977 | 6593 | 0.000 |
Why?
|
| Capillaries | 1 | 1984 | 756 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1985 | 1972 | 0.000 |
Why?
|
| Veins | 1 | 1985 | 767 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 944 | 0.000 |
Why?
|
| Arteries | 1 | 1985 | 1122 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1997 | 9586 | 0.000 |
Why?
|
| Drainage | 1 | 1985 | 1156 | 0.000 |
Why?
|
| Esophagus | 1 | 1985 | 1031 | 0.000 |
Why?
|
| Microcirculation | 1 | 1984 | 1272 | 0.000 |
Why?
|
| Kinetics | 1 | 1987 | 6370 | 0.000 |
Why?
|
| Electric Stimulation | 1 | 1983 | 1734 | 0.000 |
Why?
|
| Radiography | 1 | 1988 | 6961 | 0.000 |
Why?
|
| Lymphocytes | 1 | 1984 | 2604 | 0.000 |
Why?
|
| Pneumonectomy | 1 | 1983 | 1119 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1986 | 2478 | 0.000 |
Why?
|
| Heart | 1 | 1988 | 4403 | 0.000 |
Why?
|
| Adrenalectomy | 1 | 1977 | 346 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1977 | 883 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1977 | 1819 | 0.000 |
Why?
|
| Pituitary Neoplasms | 1 | 1977 | 1323 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1986 | 11459 | 0.000 |
Why?
|